Litcius/Paper detail

SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway

Da‐Yuan Chen, Nazimuddin Khan, Brianna J. Close, Raghuveera Kumar Goel, Benjamin C. Blum, Alexander H. Tavares, Devin Kenney, Hasahn L. Conway, Jourdan K. Ewoldt, Vipul C. Chitalia, Nicholas A. Crossland, Christopher S. Chen, Darrell N. Kotton, Susan C. Baker, Serge Y. Fuchs, John H. Connor, Florian Douam, Andrew Emili, Mohsan Saeed

2021Journal of Virology84 citationsDOIOpen Access PDF

Abstract

SARS-CoV-2 can infect various organs in the human body, but the molecular interface between the virus and these organs remains unexplored. In this study, we generated a panel of highly infectible human cell lines originating from various body organs and employed these cells to identify cellular processes commonly or distinctly disrupted by SARS-CoV-2 in different cell types. One among the universally impaired processes was interferon signaling. Systematic analysis of this pathway in diverse culture systems showed that SARS-CoV-2 targets the proximal JAK-STAT pathway components, destabilizes the type I interferon receptor though ubiquitination, and consequently renders the infected cells resistant to type I interferon. These findings illuminate how SARS-CoV-2 can continue to propagate in different tissues even in the presence of a disseminated innate immune response.

Topics & Concepts

BiologyJAK-STAT signaling pathwayJanus kinaseInterferonInnate immune systemViral replicationVirologyVirusSignal transductionstatCell biologyTyrosine kinase 2Tyrosine kinaseReceptorImmune systemImmunologyGeneticsSTAT3Platelet-derived growth factor receptorGrowth factorSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19